|

Dual-target CAR-NK cells Clinical Trials

5 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1: 2Phase 1/2: 3

Top Sponsors

Beijing Biotech5

Indications

Cancer5
Recurrent Glioblastoma2
Malignant Glioma2
Glioblastoma2
Lung Cancer2

Other5 trials

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

Phase 1/2

Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC

Phase 1/2

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Phase 1/2

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Phase 1

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.